Encapsulation of Aconitine in Self-Assembled Licorice Protein Nanoparticles Reduces the Toxicity In Vivo by Li-jing Ke et al.
NANO EXPRESS Open Access
Encapsulation of Aconitine in Self-
Assembled Licorice Protein Nanoparticles
Reduces the Toxicity In Vivo
Li-jing Ke1, Guan-zhen Gao1, Yong Shen2, Jian-wu Zhou1* and Ping-fan Rao1
Abstract
Many herbal medicines and compositions are clinically effective but challenged by its safety risks, i.e., aconitine (AC)
from aconite species. The combined use of Radix glycyrrhizae (licorice) with Radix aconite L. effectively eliminates
toxicity of the later while increasing efficacy. In this study, a boiling-stable 31-kDa protein (namely GP) was purified
from licorice and self-assembled into nanoparticles (206.2 ± 2.0 nm) at pH 5.0, 25 °C. The aconitine-encapsulated GP
nanoparticles (238.2 ± 1.2 nm) were prepared following the same procedure and tested for its toxicity by
intraperitoneal injection on ICR mouse (n = 8). Injection of GP-AC nanoparticles and the mixed licorice-aconite
decoction, respectively, caused mild recoverable toxic effects and no death, while the aconitine, particle-free GP-AC
mixture and aconite decoction induced sever toxic effects and 100 % death. Encapsulation of poisonous alkaloids
into self-assembled herbal protein nanoparticles contributes to toxicity attenuation of combined use of herbs,
implying a prototype nanostructure and a universal principle for the safer clinical applications of herbal medicines.
Keywords: Radix glycyrrhizae, Radix aconite lateralis preparata, Protein nanoparticles, Aconitine encapsulation,
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Background
Aconitine (AC), known as devil’s helmet, is a highly poi-
sonous alkaloid derived from various aconite species.
Aconitine and its derivatives are the major effective but
also toxic compositions of a Chinese medicinal herb, lat-
eral roots of Aconitum carmichaelii Debx (Radix aconite
lateralis, Sichuan aconite root) [1, 2], and an Indian
herbal medicine, roots of Aconitum heterophyllum Wall
(Atis) [3]. Including more than 300 species worldwide,
the plants from genus Aconitum are used for treating
diseases or ailments such as rheumatic arthritis, cold,
and pain [3]. Despite its cardiotoxic and neurotoxic
risks, aconitine is popularly used as the antipyretic and
analgesic agents in many Asian countries. It is difficult
to calculate appropriate dosage for the use of aconitine
due to its narrow therapeutic index [4].
As an essential measure for clinical practice of traditional
Chinese medicine, it is recommended that the aconite roots
shall be used together with roots of Glycyrrhiza uralensis
Fisch (Radix glycyrrhizae, Gan-Cao, licorice root) to elimin-
ate the toxicity and improve efficacy [5, 6]. It has been
known that liquiritin from licorice forms complexation with
aconitine and therefore reduces the amount of free aconit-
ine [7], indicating that interactions between aconitine with
other major amphiphilic compounds (i.e., protein) from lic-
orice may facilitate the formation of aconitine complex of
such kind, too.
Micro/nano-structures composed of self-assembled pro-
tein have been studied with proteins from different natural
products, i.e., whey protein, casein, soy protein, and zein,
for their potential as efficient and safe carriers for nutrients
and drugs [8, 9]. When exposed to biological medium or
multiple composition dispersions like herbal decoction,
protein corona formed on the nanoparticles (NPs) diversely
alters the biological fate and pharmaceutical efficacy of par-
ticles [10]. The intracellular protein extracts of a fungal
strain Pycnoporus sanguineus was used as reducing and sta-
bilizing agents to synthesize AuNPs with various shapes
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and dimensions, which present good catalyzing ability on
the degradation of 4-nitroaniline [11].
Like many Chinese medicinal herbs, licorice root has
high content of soluble proteins, some of which are gly-
cated and remain soluble even in the boiling decoction.
The ephedrine alkaloid-containing colloidal nanoparti-
cles discovered in another licorice containing Chinese
medicinal decoction [12] imply that licorice root pro-
teins would hypothetically interact with aconitine to
form aggregates thereafter affecting the toxicity. To elu-
cidate this assumption, one of the major proteins from
Radix glycyrrhiza, namely GP, was purified and used to
construct NPs with aconitine embedded. Toxicity of the
NPs was tested in vivo in comparison to pure aconitine,
aconite, and licorice root decoction and reported here.
Methods
Materials
Aconitum carmichaelii Debx lateral root (Radix aconite
Lateralis, Sichuan aconite root) and Glycyrrhiza uralensis
Fisch., root and rhizome (Radix glycyrrhizae, Gan-Cao,
licorice root) were purchased from Beijing Shuang-qiao-
yan-jing Medicinal Material Factory, Co., Ltd. (Beijing,
China) and authenticated by Prof. Chengzi Yang from
Fujian University of Traditional Chinese Medicine. Voucher
specimens were deposited at the Museum of Traditional
Chinese Medicine, Fujian University of Traditional Chinese
Medicine (Fuzhou, China), under the identification
code: Radix aconite Lateralis (SQYJ-201303113SC6004)
and Radix glycyrrhizae (SQYJ-201306062 NM1202).
Aconitine (batch no. 20130525, HPLC purity >98.5 %)
was provided by Fujian FDA, China.
Preparation of Herbal Decoctions
Aconite lateral roots (30 g), licorice roots (30 g), and the
equal mixture of both herbs (w/w = 30/30 g) were
soaked in deionized water for 30 min and boiled for
30 min. The decoction was centrifuged at 12,000g, 25 °C
for 15 min. The supernatants were collected and diluted
to constant volume of 150 mL.
Purification of Licorice Root Protein (GP)
The sundried licorice roots (200 g) were grinded into a
fine powder and extracted with 20 mM phosphates buffer
(pH 7.2, 100 mM NaCl) at a ratio of 1:5 (w/v) for 12 h at
4 °C. The extract was adjusted to pH 9.8–10 to remove
glycyrrhizic acid. The crude protein extract was obtained
by ethanol precipitation (40~60 %) and applied to li-
quid chromatographic isolations described as below: (1)
Macro-Prep® High-Q anionic exchange chromatographic
column (10 × 250 mm): pre-equilibrated with 20 mM
Tris–HCl (pH 8.0); linear elution gradient 0~0.5 M NaCl,
200 mL; (2) POROS®R1 hydrophobic chromatographic
column (10 × 250 mm), pre-equilibrated with deionized
water, and eluted with linear 0~100 % acetonitrile gradient
at 1.0 mL/min.
Preparation of GP Nanoparticles (GP NPs) and GP-
Aconitine Nanoparticles (GP-AC NPs)
The GP solution (0.46 mg/mL) was adjusted with 1 M
HCl to pH 5.0 and placed at 20–25 °C for 10 min, for self-
assembly of GP NPs. The GP-AC NPs were prepared by
the same procedure with the addition of 10 μL methanol
aconitine solution (20 mg/mL) in 1990 μL GP solution.
The size and ζ-potential of particles were characterized
with dynamic light scattering analysis (DLS) on a Zetasizer
Nano device (Malvern Instruments, Worcestershire, UK)
and size-exclusive HPLC (TSK gel G6000PW, 7.8 mm×
30 cm, 20 mM pH 7.2 phosphates buffer at 0.5 mL/min,
280 nm UV detection).
Protein SDS-PAGE
The GP was analyzed with standard SDS-PAGE in 4 %
concentrating gel and 12.5 % separating gel and stained
with Coomassie brilliant blue G-250 according to Laemmli
method [13], with a protein gel electrophoresis device
(ATTO, Japan).
Protein Content Determination
The protein concentration was determined with Folin-
phenol assay [14] with bovine serum albumin as stand-
ard sample.
Scanning Electron Microscopy (SEM)
SEM samples were prepared according to Rudiger’s method
[15], the nanoparticles suspension was gently collected with
0.22 μm cellulose acetate membrane, fixed and dehydrated,
and dried and coated with gold. The NPs on the
membrane was then imaged with a Cold Field Emission
S-4800 Scanning Electron Microscope (Hitachi, Tokyo,
Japan) operated under an acceleration voltage of 5 kV.
The images were taken with 100,000 (500-nm scale bar)
and 25,000 magnification (2-μm scale bar).
Quantification of Aconitine
The content of AC was determined with reversed-phase
liquid chromatography (RPLC) column Eurospher 100-5
C18 (250 × 4.6 mm, 5 μm), eluted with a gradient of so-
lution A (acetonitrile–tetrahydrofuran, 25:15, v/v) and
solution B (0.1 mol/L ammonium acetate, 0.5 mL/L gla-
cial acetic acid) [16, 17]. The percentage of solution A
raised from 15 to 20 % in 40 min and stayed at 20 % for
10 min. Flow rate was 1.0 mL/min, UV detector wave-
length at 250 nm, and column temperature at 35 °C.
The AC concentration was calculated according to the
standard curve.
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Encapsulation Rate of Aconitine in GP-AC NPs
The suspension of GP-AC NPs was filtrated with ultrafil-
tration tubes (MW cutoff 100 kDa). The AC content of
the filtrates was determined with the above method. The
encapsulation rate was calculated with equation below.
E ¼ C−C1C (C: total AC in suspension; C1: AC in filtrates)
Mouse Acute Toxicity Test
The herbal extracts (0.4 mL/mice) and GP-AC NPs sus-
pension/solution (0.2 mL/mice) were given to healthy
ICR mouse (weight 15 ± 1.0 g, eight per group) by intra-
peritoneal injection (as shown in Table 1). The toxic re-
sponse was recorded 3 h after the injection [18].
Results and Discussion
Results
Purification of the Major Protein from Radix Glycyrrhizae
The licorice proteins were extracted from the sun-dried
Radix glycyrrhizae and firstly separated by ethanol pre-
cipitated. As shown in Fig. 1, the crude extracts contain
proteins with molecular weights ranged from 14.0 to
66.2 kDa. Among which the protein with molecular
weight around 31.0 kDa has the highest content and
remained in the decoction of licorice. This protein was
purified with anionic exchange liquid chromatography
(High-Q), followed by hydrophobic liquid chromatog-
raphy (POROS® R1), and named as GP. The purity was
certified with SDS-PAGE as shown in Fig. 1. The PI of
GP was 4.5 determined with gel electrophoresis.
Either GP alone or mixture of GP and AC self-
assembled into near-spherical colloidal nanostructures (as
shown in Fig. 2) at pH 5.0, at protein concentration of
460 μg/mL and AC content of 100 μg/mL. The average
diameter of GP nanoparticles (GP NPs) is 206.2 ± 2.0 nm
(Fig. 3a), while the diameter distributes are from 100 to
500 nm. Addition of AC increased the mean diameter of
particles, which is 238.2 ± 1.2 nm, and extended the
diameter distribution of particles up to 900 nm.
Quantification of AC Content and Calculation of
Encapsulation Rate
The AC content of aconite decoction, mixed licorice-
aconite decoction, GP-AC mixture, and ultrafiltration fil-
trates were quantified with RPLC method and regression
equation of AC standard curve (y = 25,069x − 54,187, R2 =
0.9997).
There was 93.89 μg/mL AC in GP-AC mixture before
ultrafiltration whereas 67.39 μg/mL AC in filtrates; the
implied 28.2 % of AC was encapsulated into the GP-AC
NPs. Given that the protein content in GP-AC NPs was
244.6 μg/mL, determined with Lowry assay, the molecu-
lar weight ratio of GP/AC in the NPs was 9.2/1, which is
equal to 1:5.2 in molar ratio. For reference, the AC con-
tents of aconite decoction (group B) and mixed licorice-
aconite decoction (group C) used in the toxicity test
were 20.1 and 3.1 μg/mL, respectively.
The GP-AC NPs remained rather stable at 25 °C, as
indicated by the constant monitoring of particle size
(diameters) and ζ-potential for 7 days (Fig. 4). The average
diameter increased mildly by 50 nm (<25 %) after 7 days,
while the variation of which increased along the ex-
tension of time. The ζ-potential during the period
fluctuated slightly but stayed in a narrow range be-
tween −10 and −16 mV, with an increased variation.
Table 1 Groups in acute toxicity tests in mice by intraperitoneal
injection
Group Mouse Samples and dosage (per mice)
A 8 Licorice decoction (30 g licorice), 0.4 mL (AC = 0 μg)
B 8 Aconite decoction (30 g aconite), 0.4 mL (AC = 8.0 μg)
C 8 Licorice + aconite decoction (30 g licorice, 30 g aconite),
0.4 mL (AC = 1.2 μg)
1 8 Tris–HCl buffer pH 5.0, 0.2 mL
2 8 Aconitine dissolved in Tris–HCl buffer (pH 5.0), 0.2 mL
(AC = 10.0 μg)
3 8 GP-AC colloidal dispersion contains NPs, GP, AC, 0.2 mL
(AC = 10.0 μg)
4 8 Filtrates solution contains GP and AC, 0.2 mL (AC = 10.0 μg)
5 8 GP-AC NPs dispersion, 0.2 mL (AC = 10.0 μg)
Fig. 1 SDS-PAGE of Radix glycyrrhizae proteins. Samples: M marker;
Lane1, crude extract of Radix glycyrrhizae; GP, licorice protein.
Electrophoresis was performed at following conditions: 12.5 % gel, 120 V,
25 μL/sample, stained with Coomassie brilliant blue. Equation for
molecular weight calculation: sample protein MW=−0.9231 ×migration
distance + 5.0148 (R2 = 0.9994)
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Fig. 2 SEM image of licorice protein (GP) nanoparticles. GP NPs were presented on the top of cellulose acetate membrane. a, b GP NPs,
amplified 100,000 times. c GP NPs, amplified 25,000 times. d empty cellulose acetate membrane
Fig. 3 Size (diameter) distribution of GP NPs and GP-AC NPs. a GP NPs diameter distribution; b GP-AC NPs diameter distribution
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There were no visible aggregates or precipitates formed
during the period of observation, indicating a potential of
GP NPs as prototype of drug vehicle.
Acute Toxicity Tests
Two lines of samples were tested for the acute toxic re-
sponse of aconitine: (1) the herbal decoctions including
licorice roots, aconite roots, mixed licorice, and aconite
roots (w/w = 1:1); (2) aconitine solution, GP-AC mixture
dispersion at pH 5.0, filtrates, and cutoff aggregates (GP-
AC NPs) of the mixture separated by ultrafiltration
(MW cutoff 100 kDa). AC contents of the second line
samples were adjusted to 50 μg/mL to give a universal
substance background for toxicity comparison.
As shown in Table 2, after intraperitoneal injection, no
toxic effects were observed among mouse received lic-
orice decoction (group A), while mouse received aconite
decoction (group B) exhibited severe toxic responses
and eventually all died at approximately 100 min after
injection. In comparison, no death was reported among
mouse received mixed licorice-aconite decoction, while
mild toxic effects were observed but subsided in 3 h.
Mouse received aconitine solution (group 2) exhibited
severe toxic effects of aconitine and died 18 min after in-
jection. Mouse received GP-AC colloidal dispersions
(containing NPs, GP, AC; group 3), and filtrates from
ultrafiltration (containing free GP and AC; group 4) ex-
hibited severe toxic effects, too, and died 30 and 50 min
after injection, respectively. The death time of mouse re-
ceived GP-AC mixtures were delayed compared to the
pure aconitine group. The mouse administrated with
particulates trapped by the membrane (GP-AC NPs and
GP NPs; group 5) only exhibited mild toxic response to
and all subsided in 3 h and survived.
Discussion
The encapsulation of AC into GP NPs increased the mean
particle diameter by 16 % in comparison to the particles of
GP alone. Similar size expanding was observed in doxo-
rubicin encapsulated BSA nanoparticles [19]. The binding
force between protein and small molecule phytochemicals
generally involves either ionic interaction, hydrogen bonds,
or hydrophobic force [20]. The water soluble compound
like ephedrine attached to the surface of protein nanoparti-
cles via secondary boundary [12], while the water insoluble
compounds like aconitine is more likely to be integrated in-
side the protein nanoparticles through boundary with
hydrophobic domain of protein. The former kind has a
loose boundary to the particles and is easy to be released
when the suspension environment become less polar (more
nonpolar), i.e., the increase of methanol concentration. The
later kind forms a much more stable supramolecular struc-
ture and is hardly broken by changing the polarity of solv-
ent, i.e., RPLC analysis. Ren et al. reported a good example
of utilizing hydrophobic binding domains within protein
(modified pyruvate dehydrogenase) nanostructure to retain
and deliver the hydrophobic antitumor compound doxo-
rubicin, with which a significant apoptosis was induced in
breast cancer cells [21].
The decoction of mixed aconite and licorice (in group C)
showed reduced toxicity in comparison to that of sole acon-
ite, as shown in Table 2 (groups A/B/C). The aconitine con-
tent in aconite decoction was 20.1 μg/mL (group B), which
dropped by 84 % to 3.1 μg/mL in the aconite-licorice de-
coction. The decrease of AC content provided an obvious
reason to the decreased toxicity in group C, while other
active compositions from licorice may have also contrib-
uted by suppressing the physiological impacts of aconitine,
i.e., 6-benzoylheteratisine, as a natural antagonist of the
Fig. 4 GP-AC particle size and ζ-potential variation over time at 25 °C. Z-average diameter of GP-AC NPs (diamond), ζ-potential of GP-AC NPs
(square). Three duplicates were performed to calculate the average value and variations
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Na+ channel activator aconitine [22]. These two factors may
work individually or synergistically. Furthermore, the drop
in AC content (group C) may be attributed to two possible
reasons: the heating during herbal material processing and
decoction preparation [3] or the complexation formation of
aconitine with other compositions in the decoction, e.g., lic-
orice protein in this study and liquiritin as reported [7]. We
assume that the key reasons are more likely to be the com-
plexation formation rather than heating, since the aconite
decoction (group B) had gone through the same boiling
process but retained higher concentration of AC.
The detoxification effects of GP encapsulation was
accessed and demonstrated in healthy mouse at 50 μg/mL
of aconitine, as shown in the schematic diagram (Fig. 5).
Table 2 Acute toxicity tests in mice by intraperitoneal injection (n = 8)
Group Dead Time to death (min) Toxic effects
a 0 – Normal
b 8 100 ± 15 Gather, eyes close, tremble, convulsions, opisthotonos position
c 0 – Gather, eyes close, less active, returned to normal in 3 h
1 0 – Normal
2 8 18 ± 5 Gather, eyes close, tremble, convulsions, opisthotonos position
3 8 30 ± 5 Gather, eyes close, tremble, convulsions, opisthotonos position
4 8 50 ± 5 Gather, eyes close, tremble, convulsions, opisthotonos position
5 0 – Gather, eyes close, less active, returned to normal in 3 h
Fig. 5 Schematic diagram of formation and detoxification of GP-AC NPs. The hydrophilic surface of GP molecules, taking a polypeptide segment
as example (bottom left in the diagram), is charged (shown as blue square and circular dot) in the aqueous solution while the hydrophobic groups
(shapes in grey) are wrapping inside the molecule. When the solution pH was adjusted to near PI (pH = 5.0), the protein surface became partially
uncharged (shown as hollow blue square and circle) which weakens the ionic dispelling force between protein molecules and facilitates the protein
aggregation. The water insoluble AC binds to the hydrophobic regions of GP during the conformational changes thereafter is encapsulated in the protein
NPs, namely GP-AC NPs. The protein encapsulation detoxified AC in the mouse
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In comparison to the 100 % death rate in pure aconitine
group (group 2), GP-AC particles showed no vital conse-
quence except some mild toxic response, i.e., gather, eyes
close, less active (group 5), implying the very difference
between the aconitine in single molecule form or in a
supramolecular structure. The size, chemical composition,
and surface properties of particulates determine the circu-
lation and metabolism profiles of nanoscale drug carriers
[19, 23]. Protein nanoparticle-based drug vehicle can im-
prove the biocompatibility and absorption while reducing
the toxicity, i.e., apotransferrin nanoparticles eliminated
cardiotoxicity of doxorubicin when provided a longer bio-
availability [24]. When the tumor cells and nonphagocytic
cells tend to absorb relatively small particles (50 to
200 nm), NPs with such diameter and hydrophilic surface
are able to escape from reticuloendothelial phagocytose [25,
26]. GP-AC NPs exceed 200 nm in diameters and is likely
to be swallowed by phagocytes (macrophages) [26], kept
out of blood circulation thereafter becoming less toxic.
Despite the similar toxic syndromes and eventual
death, the survival minutes before death varied between
groups 2, 3, and 4. The extended survival time (30 min)
in group 3, which is a mixture of NPs, GP, and AC, may
attribute to decline in the amount of free AC. As a mix-
ture of free GP and AC in group 4, the survival time was
unexpectedly extended further to 50 min. It may attri-
bute to the secondary aggregation of GP and AC in-
duced by the removal of GP-AC NPs from the otherwise
balanced suspension.
Conclusions
The encapsulation of aconitine in the pH-induced self-
assembled licorice protein NPs eliminated the toxicity of
aconitine in vivo. The study not only elucidates the self-
assembled protein NPs contribute to the detoxifying ef-
fects of licorice against aconite but also provides a new
approach and material for application of active phyto-
chemicals and herbal compositions with much less safety
concerns. On the other hand, the impacts of complexes
among multiple compositions from the natural products
should be considered in the toxicological evaluation, im-
plying the appropriate approach and technique should
be applied.
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